These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21209473)

  • 1. Quantifying exposure to calcium and phosphate in ESRD; predictive of atherosclerosis on top of arteriosclerosis?
    van Jaarsveld BC; van der Graaf Y; Vos PF; Soedamah-Muthu SS;
    Neth J Med; 2010 Dec; 68(12):431-8. PubMed ID: 21209473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Why do patients with kidney diseases end up with a heart of stone? Disturbances in calcium-phosphate balance and chronic inflammation important causes].
    Martola L; Elinder CG; Stenvinkel P
    Lakartidningen; 2003 Dec; 100(50):4180-3. PubMed ID: 14717005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of hyperphosphataemia in the cardio-renal axis.
    Goodman WG
    Nephrol Dial Transplant; 2004 Mar; 19 Suppl 1():i4-8. PubMed ID: 15126647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients.
    Stack AG; Bloembergen WE
    Am J Kidney Dis; 2001 Nov; 38(5):992-1000. PubMed ID: 11684552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of calcium on cardiovascular events in patients with kidney disease and in a healthy population.
    West SL; Swan VJ; Jamal SA
    Clin J Am Soc Nephrol; 2010 Jan; 5 Suppl 1():S41-7. PubMed ID: 20089502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients.
    Voormolen N; Noordzij M; Grootendorst DC; Beetz I; Sijpkens YW; van Manen JG; Boeschoten EW; Huisman RM; Krediet RT; Dekker FW;
    Nephrol Dial Transplant; 2007 Oct; 22(10):2909-16. PubMed ID: 17517792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium and phosphate in renal failure.
    Br Med J; 1971 Jun; 2(5764):725-6. PubMed ID: 5090754
    [No Abstract]   [Full Text] [Related]  

  • 9. [Malnutrition -- inflammation -- atherosclerosis (MIA syndrome) in patients with renal failure].
    Pawlaczyk K; Oko A; Lindholm B; Czekalski S
    Pol Merkur Lekarski; 2003 Oct; 15(88):334-41; discussion 341-3. PubMed ID: 14974361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Arteriosclerosis and vascular calcification in chronic kidney disease (CKD) patients].
    Masho Y; Shigematsu T
    Clin Calcium; 2007 Mar; 17(3):354-9. PubMed ID: 17339739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk factors of atherosclerosis in end-stage renal disease patients].
    Jono S
    Clin Calcium; 2004 Jan; 14(1):21-6. PubMed ID: 15576949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different risk factors for vascular calcification in end-stage renal disease between diabetics and nondiabetics: the respective importance of glycemic and phosphate control.
    Ishimura E; Okuno S; Taniwaki H; Kizu A; Tsuchida T; Shioi A; Shoji T; Tabata T; Inaba M; Nishizawa Y
    Kidney Blood Press Res; 2008; 31(1):10-5. PubMed ID: 18097148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphate binders, cardiovascular calcifications and mortality: do we need another survival study with sevelamer?
    Negri AL
    J Nephrol; 2010; 23(6):653-7. PubMed ID: 20349415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular calcification in nondialyzed patients with chronic kidney disease.
    Qunibi WY
    Semin Dial; 2007; 20(2):134-8. PubMed ID: 17374087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher brachial-ankle pulse wave velocity is associated with more advanced carotid atherosclerosis in end-stage renal disease.
    Munakata M; Sakuraba J; Tayama J; Furuta T; Yusa A; Nunokawa T; Yoshinaga K; Toyota T
    Hypertens Res; 2005 Jan; 28(1):9-14. PubMed ID: 15969249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardioprotection: an essential component for predialysis chronic renal failure treatment].
    Jungers P; Qualim Z; Nguyen-Khoa T; Massy Z; London G
    Nephrologie; 2003; 24(2):79-88. PubMed ID: 12723513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiovascular calcification and accelerated atherosclerosis in chronic kidney disease].
    Cozzolino M; Butti A; Chiarelli G; Rocca-Rey L; Santagostino G; Gallieni M; Brancaccio D
    Ital Heart J Suppl; 2005 Jan; 6(1):25-8. PubMed ID: 15776728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of atherosclerotic cardiovascular disease among HIV patients receiving dialysis.
    Oberai PC; Dalal D; Zhang L; Wang C; Eustace J; Parekh RS
    Am J Kidney Dis; 2006 May; 47(5):848-55. PubMed ID: 16632024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphate binders in chronic kidney disease and end-stage renal disease: a patient-centered approach.
    Novak JE; Szczech LA
    Semin Dial; 2009; 22(1):56-63. PubMed ID: 19000107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive markers of asymptomatic atherosclerosis in end-stage renal disease patients.
    Mutluay R; Konca C; Erten Y; Paşaoğlu H; Değer SM; Ağirgün C; Derici U; Arinsoy T; Sindel S
    Ren Fail; 2010 May; 32(4):448-54. PubMed ID: 20446782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.